B Fröseth
About
In The Last Decade
B Fröseth
19 papers receiving 320 citations
Peers
Comparison fields: 5 of 73
- Pulmonary and Respiratory Medicine 148
- Pharmacology 86
- Molecular Biology 50
- Physiology 49
- Infectious Diseases 46
Countries citing papers authored by B Fröseth
This map shows the geographic impact of B Fröseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Fröseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Fröseth more than expected).
Fields of papers citing papers by B Fröseth
This network shows the impact of papers produced by B Fröseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Fröseth. The network helps show where B Fröseth may publish in the future.
Co-authorship network of co-authors of B Fröseth
This figure shows the co-authorship network connecting the top 25 collaborators of B Fröseth. A scholar is included among the top collaborators of B Fröseth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Fröseth. B Fröseth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 18 | |
| 5 | 13 | |
| 6 | 31 | |
| 7 | 66 | |
| 8 | Inhaled budesonide influences cellular and biochemical abnormalities in pulmonary sarcoidosis. | 35 |
| 9 | Angiotensin-converting enzyme, lysozyme, beta-2-microglobulin and adenosine deaminase in sarcoidosis. | 3 |
| 10 | Serum lysozyme concentration in silicosis patients and workers exposed to silica dust. | 5 |
| 11 | 23 | |
| 12 | 6 | |
| 13 | 18 | |
| 14 | Assessment of the tuberculosis agglutination test. | 3 |
| 15 | 89 | |
| 16 | Clinical significance of precipitating anti-rifampicin antibodies. | 2 |
| 17 | Preliminary report on the therapeutic results using clotrimazole in lung disease patients with a C. positive sputum. | 1 |
| 18 | 1 | |
| 19 | Preliminary report on a modified method for determination of ethambutol in serum. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.